Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Jul 17, 2024 11:01am
86 Views
Post# 36136613

RE:More good news.....

RE:More good news.....
prone wrote: The cannabis market in the United States has experienced significant growth in recent years, driven largely by an increasingly favorable legal environment.

Since Colorado and Washington first legalized recreational marijuana in 2012, numerous states have followed suit, with 23 states and the District of Columbia now allowing adult-use cannabis as of 2023.

This trend has fueled a burgeoning industry, with legal cannabis sales reaching $24 billion in 2021, a sharp increase from the $8.5 billion reported in 2017.

Analysts project that the U.S. cannabis market could surpass $45 billion by 2025, supported by ongoing state-level legalizations and potential federal reforms.

This rapid growth highlights the expanding acceptance of cannabis and its economic potential, with more states considering legalization to boost tax revenues and create jobs


These predictions are meaningless as they have nothing to do with the market LABS is focused on.

Now if LABS surprises us and announces some partnership or JV or even equity stake with some powerful US based outfit, then yes, this type of trend is good news.
<< Previous
Bullboard Posts
Next >>